The application of gene therapy to restoring vision has been especially fruitful. Here we discuss the potential of gene therapy to address macular degeneration.
Category: pharma & healthcare
At Least 8 Million Medicaid Enrollees Expected To Be Dropped From Coverage This Year
Whenever a policy as far-reaching as eliminating continuous enrollment in Medicaid is considered it would seem prudent to weigh the costs of foregone alternatives.
Exploring The Potential Of Microrobots For Targeted Drug Delivery
Enhanced microrobots in our bloodstream may be the next step forward for therapeutic delivery technology.
‘Common Ground’: Tribeca Film Connects Regenerative Farming, Politics And Public Health
In new documentary, Laura Dern joins star-studded cast to explore regenerative farming, climate change, cancer and other illnesses
‘Common Ground’: Tribeca Film Connects Regenerative Farming, Politics And Public Health
In new documentary, Laura Dern joins star-studded cast to explore regenerative farming, climate change, cancer and other illnesses
Cancer Treatment CAR T Therapy Prolongs Survival Over Standard Care
Newly released study results demonstrate that Yescarta, a CAR T therapy, prolongs survival longer than standard care for patients with early relapsed or refractory DLBCL
Elon Musk Adds Fuel To The Fire Set By Anti-Vaccine Conspiracists As He Mischaracterizes Peter Hotez
Declining a debate with an anti-vaccine crusader is understandable. It would amplify and in the eyes of many viewers legitimize Kennedy as somehow an equal adversary.
No Pain, FAAH-OUT
A recent study describes a genetic mutation found in a woman who cannot feel physical pain. The study brings us closer to understanding pain and how we can treat it.
FDA Approval Of Topical Gel Eroxon For ED Reinforces Trend Toward More Availability Of OTC Products In Classes Previously Prescription-Only
Eroxon’s approval as an ED product is part of trend in which OTC availability is increasing in therapeutic classes which were formerly off limits to OTC drugs.
Merck Seeks A `Fair’ Drug Price In Lawsuit Against Inflation Reduction Act, But So Does Medicare: Neither Price Is Fair
Merck seeks a fair drug price in lawsuit against the IRA, but so does Medicare. Neither price Is fair. Merck and Medicare use notions of fairness untethered to value.
